agilon health, inc.

AGL NYSE SEC CIK 1831097
Follow agilon health Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.5B +5.9% vs same quarter last year
Net income $34.9M +131.7% vs same quarter last year
EPS, diluted $1.97 +129.6% vs same quarter last year
Operating cash flow $49.9M +374.7% vs same quarter last year
Revenue by quarter
$1.5B
$1.5B
$1.4B
$1.4B
$1.6B
$1.4B
$1.5B
$1.5B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$2B$0$2B$4B$6B$8BFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$5.9B−$391.3M
FY24$6.1B−$260.2M
FY23$4.3B−$262.6M
FY22$2.4B−$106.6M
FY21$1.5B−$406.5M
FY20$1.2B−$60.1M
FY19$794.4M−$282.6M
FY18--
MarginsShare of revenue
  • Operating margin
  • Net margin
−40%−30%−20%−10%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−7.8%−6.6%
FY24−4.8%−4.3%
FY23−5.4%−6.1%
FY22−4.4%−4.5%
FY21−24.5%−26.7%
FY20−4.7%−4.9%
FY19−13.4%−35.6%
FY18--
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$119M
FY24−$71M
FY23−$172M
FY22−$146.2M
FY21−$154.7M
FY20−$55M
FY19−$106.8M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • agilon health
  • Healthcare median
−100%−75%−50%−25%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
Yearagilon healthHealthcare median
FY25−6.6%−30.6%
FY24−4.3%−47%
FY23−6.1%−58%
FY22−4.5%−80.4%
FY21−26.7%−71.9%
FY20−4.9%−62.2%
FY19−35.6%−46.3%
FY18-−49.6%